Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · IEX Real-Time Price · USD
280.16
-5.50 (-1.93%)
At close: Jun 28, 2024, 4:00 PM
279.88
-0.28 (-0.10%)
After-hours: Jun 28, 2024, 7:48 PM EDT
Madrigal Pharmaceuticals Market Cap
Madrigal Pharmaceuticals has a market cap or net worth of $5.97 billion as of June 28, 2024. Its market cap has increased by 34.12% in one year.
Market Cap
5.97B
Enterprise Value
5.03B
1-Year Change
34.12%
Ranking
Category
Stock Price
$280.16
Market Cap Chart
Since March 28, 2007, Madrigal Pharmaceuticals's market cap has increased from $288.50M to $5.97B, an increase of 1,969.54%. That is a compound annual growth rate of 19.18%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 28, 2024 | 5.97B | -1.93% |
Jun 27, 2024 | 6.09B | 3.74% |
Jun 26, 2024 | 5.87B | -1.67% |
Jun 25, 2024 | 5.97B | -1.39% |
Jun 24, 2024 | 6.05B | 2.00% |
Jun 21, 2024 | 5.93B | 3.97% |
Jun 20, 2024 | 5.71B | -2.98% |
Jun 18, 2024 | 5.88B | -0.26% |
Jun 17, 2024 | 5.90B | -0.31% |
Jun 14, 2024 | 5.92B | 0.21% |
Jun 13, 2024 | 5.90B | -3.08% |
Jun 12, 2024 | 6.09B | -2.11% |
Jun 11, 2024 | 6.22B | 14.56% |
Jun 10, 2024 | 5.43B | 4.31% |
Jun 7, 2024 | 5.21B | 1.24% |
Jun 6, 2024 | 5.14B | 2.28% |
Jun 5, 2024 | 5.03B | -3.43% |
Jun 4, 2024 | 5.21B | -0.46% |
Jun 3, 2024 | 5.23B | 3.95% |
May 31, 2024 | 5.03B | 4.73% |
May 30, 2024 | 4.81B | 1.34% |
May 29, 2024 | 4.74B | -0.35% |
May 28, 2024 | 4.76B | -2.74% |
May 24, 2024 | 4.89B | -2.24% |
May 23, 2024 | 5.01B | -0.09% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Halozyme Therapeutics | 6.66B |
Exelixis | 6.55B |
Revolution Medicines | 6.40B |
Acadia Healthcare Company | 6.27B |
Cytokinetics | 6.21B |
Glaukos | 5.96B |
Viking Therapeutics | 5.85B |
Tempus AI | 5.78B |